SWM
AGTC

Spire Wealth Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Spire Wealth Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,500
Closed -$23K – 3076
2021
Q1 		$23K Buy
+4,500
New +$23.3K ﹤0.01% 2101

Other funds holding AGTC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Spire Wealth Management's AGTC Position: Q2 2021 in Review

Spire Wealth Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 4,500 shares — an estimated $23K sold.

Spire Wealth Management first reported a position in AGTC in Q1 2021 and held it in 1 quarter. The position peaked at $23K in Q1 2021. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Spire Wealth Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Spire Wealth Management sold 4,500 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $23K.
  • Spire Wealth Management first reported a position in Applied Genetic Technologies Corporation in Q1 2021 and held it in 1 quarter.
  • Spire Wealth Management's Applied Genetic Technologies Corporation position peaked at $23K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Spire Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.